Ignite Creation Date:
2024-05-06 @ 8:27 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06381206
Status:
COMPLETED
Last Update Posted:
2024-04-24
First Post:
2024-02-09
Brief Title:
Silodosin in Management of Lower Ureteral Stones
Sponsor:
Syrian Private University
Organization:
Syrian Private University
Study Overview
Official Title:
The Use of Selective Alpha Blockers Silodosin in Management of Lower Ureteral Stones Larger Than 6 mm in Diameter
Status:
COMPLETED
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This research aims to study the effectiveness of silodosin in the management of lower ureter stones larger than 6 mm in diameter in terms of affected ureter right or left the size of the stone the degree of hydronephrosis the rate of stone expulsionday whether the stone was completely expelled or not and the side effects of silodosin
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None